-- Winners across biotechnology, digital health, medical technology, pharmaceuticals, public sector, and health equity categories honoured at prestigious Awards Ceremony LONDON, June 12, 2026...
BURLINGAME, Calif., June 11, 2026 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and...
Four self-developed product lines — servo press, transducerized tightening, automatic screw feeding, and Centron precision dispensing — support Southeast Asia's accelerating EV and automotive manufacturing...
LAS VEGAS, June 11, 2026 (GLOBE NEWSWIRE) -- HF Foods Group Inc. (NASDAQ: HFFG), a leading distributor of international foodservice solutions to Asian restaurants and other businesses across the United States, announces that its Board of Directors (the “Board”) has approved a limited duration stockholder rights plan (the “Rights Plan”) and declared a dividend distribution of one right (“Right”) for each outstanding share of the Company’s common stock to stockholders of record as of the close of business on June 22, 2026.
CHICAGO, June 11, 2026 /PRNewswire/ -- Cars.com Inc. (NYSE: CARS) ("Cars.com" or the "Company"), today announced that on June 5, 2026, the Company's Compensation...
WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Via Transportation, Inc. (NYSE: VIA) pursuant and/or traceable to the registration statement and related prospectus (collectively, the "Offering Documents") issued in connection with Via's initial public offering (the "IPO" or “Offering”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 10, 2026.
DALLAS, June 11, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, announced today that it has entered into securities purchase agreements for the purchase and sale of 3,883,496 shares of its common stock (or pre-funded warrants in lieu thereof), Series A-1 preferred investment options to purchase up to an aggregate of 3,883,496 shares of common stock and Series A-2 preferred investment options to purchase up to an aggregate of 3,883,496 shares of common stock at a purchase price of $1.03 per share of common stock (or pre-funded warrant in lieu thereof) and associated preferred investment options in a private placement priced at-the-market under Nasdaq rules.
In the news release, LEVERAGED FINANCE FIGHTS MELANOMA RAISES RECORD $4.3 MILLION FOR THE MELANOMA RESEARCH ALLIANCE, issued 11-Jun-2026 by Melanoma Research Alliance over...
Expansion strengthens production capacity, shortens lead times, and broadens custom radiation shielding solutions.LAGUNA BEACH, Calif., June 11, 2026 /PRNewswire/ -- Lead Glass Pro, a...
ALPHARETTA, Ga., June 11, 2026 /PRNewswire/ -- When does mosquito season truly begin in Alpharetta, and why does it last so long? According to HelloNation,...